Hollsteen
← Reddit

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q1 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2021: −$286M · 10-K 0001713445-25-000018 filed Feb 13, 2025Equity incl. NCI · Q1 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 2022: −$379M · 10-K 0001713445-25-000018 filed Feb 13, 2025Equity incl. NCI · Q1 2023: −$428M · 10-Q 0001713445-24-000006 filed May 8, 2024Equity incl. NCI · Q2 2023: −$458M · 10-Q 0001713445-24-000054 filed Aug 7, 2024Equity incl. NCI · Q3 2023: −$455M · 10-Q 0001713445-24-000102 filed Oct 30, 2024Equity incl. NCI · Q4 2023: −$413M · 10-K 0001713445-25-000018 filed Feb 13, 2025Equity incl. NCI · Q1 2024: $1.8B · 10-Q 0001713445-24-000006 filed May 8, 2024Equity incl. NCI · Q2 2024: $1.9B · 10-Q 0001713445-24-000054 filed Aug 7, 2024Equity incl. NCI · Q3 2024: $2.0B · 10-Q 0001713445-24-000102 filed Oct 30, 2024Equity incl. NCI · Q4 2024: $2.1B · 10-K 0001713445-25-000018 filed Feb 13, 2025Equity incl. NCI · Q1 2025: $2.2B · 10-Q 0001713445-25-000102 filed May 2, 2025Equity incl. NCI · Q2 2025: $2.4B · 10-Q 0001713445-25-000196 filed Aug 1, 2025Equity incl. NCI · Q3 2025: $2.6B · 10-Q 0001713445-25-000227 filed Oct 31, 2025Equity incl. NCI · Q4 2025: $2.9B · 10-K 0001713445-26-000022 filed Feb 6, 2026Equity incl. NCI · Q1 2026: $3.2B · 10-Q 0001713445-26-000069 filed May 1, 2026Equity incl. NCI · Q2 2026: $3.3B · 10-Q 0001713445-26-000100 filed Jul 31, 2026missing3,286−286Q1 2016Q2 2026Q2 2021
$MEquity incl. NCI · Q3 2024: $2.0B · 10-Q 0001713445-24-000102 filed Oct 30, 2024Equity incl. NCI · Q4 2024: $2.1B · 10-K 0001713445-25-000018 filed Feb 13, 2025Equity incl. NCI · Q1 2025: $2.2B · 10-Q 0001713445-25-000102 filed May 2, 2025Equity incl. NCI · Q2 2025: $2.4B · 10-Q 0001713445-25-000196 filed Aug 1, 2025Equity incl. NCI · Q3 2025: $2.6B · 10-Q 0001713445-25-000227 filed Oct 31, 2025Equity incl. NCI · Q4 2025: $2.9B · 10-K 0001713445-26-000022 filed Feb 6, 2026Equity incl. NCI · Q1 2026: $3.2B · 10-Q 0001713445-26-000069 filed May 1, 2026Equity incl. NCI · Q2 2026: $3.3B · 10-Q 0001713445-26-000100 filed Jul 31, 20263,2861,978Q3 2024Q2 2026Q3 2025
Q2 2026
3,286$M
All values (16)
PeriodValue ($M)Status
Q2 20263,286reported
Q1 20263,180reported
Q4 20252,929reported
Q3 20252,611reported
Q2 20252,387reported
Q1 20252,217reported
Q4 20242,131reported
Q3 20241,978reported
Q2 20241,894reported
Q1 20241,838reported
Q4 2023−413reported
Q3 2023−455reported
Q2 2023−458reported
Q1 2023−428reported
Q4 2022−379reported
Q1 2022 – Q3 2022–missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods.
Q4 2021Noneerror
Q1 2016 – Q3 2021–missing (23 periods): Grund wie bei Q1 2022 – Q3 2022.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Reddit

Income statement

Per share

Balance sheet

Cash flow

Revenue by segment/product/region

Sources & calculation
Value
$3.3B
Period
Q2 2026, ended Jun 30, 2026 · as of Jun 30, 2026 (balance as of date, not a sum)
Source
10-Q, filed Jul 31, 2026 · 0001713445-26-000100
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.3BJul 31, 202610-Q 0001713445-26-000100reported · confidence 1. · current